Pharmaceutical manufacturers require reliable high-purity water for equipment rinsing, solution preparation, cleaning processes, and other critical production applications. Water quality must remain stable because ionic impurities, silica, microorganisms, and organic contaminants may affect product quality, equipment cleanliness, and regulatory compliance.

A continuous electrodeionization system using Veolia EDI membrane stacks can be installed downstream of reverse osmosis to continuously remove residual ions from the water. Compared with conventional mixed-bed ion exchange systems, EDI can operate with low or no chemical regeneration during normal operation, helping reduce chemical handling and simplify water treatment management.

What Problems Does the Pharmaceutical Industry Need to Solve?

Pharmaceutical water systems may experience the following challenges:

• Residual ionic impurities after reverse osmosis

• Unstable conductivity or resistivity

• Silica and weakly ionized contaminant breakthrough

• Frequent replacement or regeneration of polishing equipment

• Chemical storage and handling requirements

• Inconsistent water quality during continuous production

• Risk of contamination in distribution loops

• Difficulties maintaining documented operating parameters

• High maintenance requirements for aging deionization systems

The core challenge is:

How to produce stable, high-purity water continuously while reducing chemical consumption, operational complexity, and contamination risks.

How Veolia EDI Membrane Stacks Work

EDI is a water treatment technology that combines ion exchange resin, ion-selective membranes, and a direct-current electric field.

A typical EDI process works as follows:

1. Reverse osmosis removes most dissolved salts, particles, microorganisms, and organic contaminants.

2. RO permeate enters the EDI stack.

3. Residual cations and anions are captured by ion exchange media.

4. The electric field drives cations and anions through selective membranes toward the concentrate compartments.

5. Purified water leaves the dilute compartments as deionized product water.

6. Concentrate and electrode streams are discharged or managed according to the system design.

A simplified process flow is:

Pretreated Water → Reverse Osmosis → Veolia EDI Membrane Stack → UV Treatment or Final Polishing → Purified-Water Storage Tank → Distribution Loop

The actual design depends on feedwater quality, required conductivity or resistivity, flow rate, temperature, carbon dioxide level, silica concentration, and pharmaceutical water standards.

Benefits for Pharmaceutical Manufacturers

Continuous Deionization

EDI can continuously remove residual ions without the routine acid and caustic regeneration typically required by conventional ion exchange polishing systems.

Reduced Chemical Handling

Lower chemical regeneration requirements may simplify chemical storage, handling, wastewater management, and operating procedures.

Stable Product Water Quality

When correctly designed and operated, EDI can provide consistent deionized water quality downstream of RO.

Improved System Automation

EDI systems can be integrated with conductivity, resistivity, flow, pressure, temperature, and alarm monitoring for centralized operation.

Reduced Downtime

Continuous operation can reduce interruptions associated with conventional resin regeneration and replacement activities.

Suitable for Modular Expansion

EDI capacity can often be configured through multiple modules or stacks, allowing the system to support phased production expansion.

Recommended System Configuration

A pharmaceutical high-purity water system may include:

• Raw-water pretreatment

• Multimedia filtration

• Activated carbon or alternative dechlorination treatment

• Water softening or antiscalant dosing, where appropriate

• Cartridge filtration

• Reverse osmosis

• Veolia EDI membrane stacks

• Ultraviolet treatment

• Ultrafiltration or final membrane polishing

• Sanitizable storage and distribution loop

• Online conductivity or resistivity monitoring

• Total organic carbon and microbiological control, where required

EDI should not be used as a substitute for proper pretreatment. High levels of hardness, chlorine, iron, oil, suspended solids, or organic contamination may damage performance or shorten stack service life.

Selection Information for Buyers

Before requesting a quotation, provide:

• RO permeate analysis

• Inlet conductivity

• Silica concentration

• Carbon dioxide concentration

• Hardness and alkalinity

• Temperature range

• Required product-water flow rate

• Required conductivity or resistivity

• Available electrical power

• Existing EDI model and dimensions, if replacing a stack

• Connection type and installation space

• Delivery country and destination port

For replacement projects, the existing stack nameplate, model number, serial number, connection dimensions, and operating history are especially important.

Frequently Asked Questions

Can a Veolia EDI membrane stack operate directly with raw water?

No. EDI normally requires suitable RO permeate or similarly pretreated water. Raw water must first undergo appropriate pretreatment and desalination.

Does EDI require acid and caustic regeneration?

EDI is designed for continuous electrochemical regeneration during operation and generally does not require routine chemical regeneration in the same way as conventional mixed-bed deionization. Cleaning or special maintenance may still be required depending on the system and feedwater.

Is EDI suitable for pharmaceutical water systems?

EDI may be used as part of a pharmaceutical high-purity water system. The complete system must be designed, qualified, operated, sanitized, and monitored according to the applicable standards and the customer’s validation requirements.

Can you supply replacement EDI stacks?

Replacement availability depends on the exact Veolia model, system configuration, connection dimensions, electrical requirements, and supply channel. These details should be confirmed before purchase.

Request a Quote

If you are sourcing Veolia EDI membrane stacks for pharmaceutical water treatment, send us your existing equipment information and water analysis. We can help coordinate specification confirmation, technical documentation, replacement compatibility review, export packaging, and international delivery.